Figure 1.

How prevalence depends on frequency and multiplicity of infection (MOI). The marker has a 10% selective advantage over the wildtype form and its frequency is increasing over time. The corresponding prevalence of the marker is shown over the same time scale assuming each human in the population contains either 2, 3, or 5 malaria clones (MOI = 2,3,5).